The N.N. Alexandrov National Centre beings Phase II case-control clinical trial of its immune-oncology agent called Elenagen. The Study Inoperable late-stage cancer patients with triple-negative…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.